Back

Inflammation and LDL cholesterol contribute independently to the progression of early human atherosclerotic plaque

30 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Risk factors (4) Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Guiomar Mendieta Badimon

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)

6 More presentations in this session

Presentation thumbnail
Polygenic prediction of cardiorespiratory fitness and relation to cardiovascular disease: the HUNT study
Miss M. Klevjer (Trondheim, NO)
Abstract Slides Video
Presentation thumbnail
A blood-based biomarker score for monitoring secondary prevention in coronary artery disease
Doctor B. Schmitz (Ennepetal, DE)
Abstract Slides Video
Presentation thumbnail
Coronary calcium score may better discriminate against high-risk subjects with little conventional cardiovascular risk factors
Doctor G. Bettencourt Abreu (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
The association between computed tomography-derived epicardial adipose tissue volume and major adverse cardiovascular events: a systematic review and meta-analysis
Ms E. Aldous (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Derivation and validation of the incremental prognostic value of increased triglyceride glucose index
Doctor S. Athanasopoulos (GR)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors (4)

The Event

Event poster

ESC Congress 2025

30 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Association between neutrophil count, LDL-C, and long-term carotid plaque progression
thumbnail
Congress Presentation
Interleukin-8 plasma levels correlate with changes in coronary atherosclerosis in patients with acute myocardial infarction treated with alirocumab
thumbnail
Congress Presentation
Residual inflammation, cholesterol risks and rates of major cardiovascular events in routinely cared patients with atherosclerotic cardiovascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources